C-Myc functions as a competing endogenous RNA in acute promyelocytic leukemia

Ye Ding1, Ze-Chuan Wang1, Yi Zheng1

  • 1Union Clinical Medical College, Fujian Medical University, Fuzhou, P.R. China.

Oncotarget
|August 4, 2016
PubMed

Insights

Competing endogenous RNAs (ceRNAs) regulate gene expression. In acute promyelocytic leukemia (APL), c-Myc mRNA acts as a ceRNA for PML/RARα, impacting disease progression via microRNA interactions.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Regulation

Background:

  • Post-transcriptional regulation involves RNA transcripts competing for microRNAs (miRNAs).
  • These competing endogenous RNAs (ceRNAs) modulate miRNA distribution and target accessibility.
  • Chromosomal translocations in acute promyelocytic leukemia (APL) can disrupt ceRNA networks.

Purpose of the Study:

  • To investigate the role of ceRNA interactions in APL pathogenesis.
  • To determine if c-Myc mRNA functions as a ceRNA for the PML/RARα oncogene in APL.

Main Methods:

  • Analysis of c-Myc mRNA and PML/RARα expression in APL cells.
  • Investigation of miRNA-dependent repression of PML/RARα by c-Myc.
  • Assessment of let-7 miRNA family activity and target regulation.

Main Results:

  • c-Myc mRNA represses PML/RARα expression in a miRNA-dependent manner, independent of its protein-coding function.
  • Reduced c-Myc transcript levels induce PML/RARα-degraded cellular phenotypes in APL cells.
  • let-7 miRNAs promote differentiation in ATRA-treated NB4 cells, with activity influenced by c-Myc and PML/RARα levels.

Conclusions:

  • c-Myc mRNA acts as a ceRNA for PML/RARα in APL by sequestering let-7 miRNAs.
  • This ceRNA interaction represents a novel regulatory mechanism in APL.
  • Targeting this c-Myc/PML-RARα ceRNA axis may offer therapeutic strategies for APL.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K